 NEW YORK, Dec. 23, 2020 PRNewswire -- Hoth Therapeutics, Inc. NASDAQ: HOTH, a biopharmaceutical company, today announced the request for a Pre-Investigational New Drug IND meeting to the U.S. Food and Drug Administration FDA to discuss the proposed drug development program for... 